Spinocerebellar Ataxia (SCA)
Spinocerebellar Ataxia is also known as SCA trophy or SCA degeneration, is a progressive degenerative genetic disease. SCA is a hereditary progressive degenerative and often fatal. SCA can affect anyone of any age. The disease is caused by either a recessive or dominant gene. In many cases, people are not aware that they are carrying a relevant gene until they have a children who began to show signs of having the disorder.
Types of Spinocerebellar Ataxia
Treatment of Spinocerebellar Ataxia
There's no treatment specifically for ataxia. In some cases treating the underlying cause revolves the ataxia, such as meditations that cause it. It one of the most devastating symptoms of many neurodegenrative disorders. Till date there is no effective treatment to retard its progression. Mesenchymal stem cells (MSN) have shown promise in treating neurodegenrative diseases.
MSCs given by intravenous injection seems to be safe and tolerable in patients with Spinocerebellar ataxia (SCAs) type 3, this supporting advancement of the clinical development of allogenic MSCs for the treatment of Spinocerebellar ataxia (SCAs) in a randomized, double - blind, placebo - controlled phase 2nd trials.
The best treatment option for Spinocerebellar ataxia (SCA) vary and often depend on the signs and symptoms present in each person. Physical therapy can help strengthen muscles, while special devices like cane, crutches, Walker, walking stick or wheelchair can assist in mobility and other activities of daily life.
Research in Spinocerebellar Ataxia
Research helps us in better understanding diseases, and can lead to advances in diagnosis and treatment. Genetic testing is available for many different gene known to cause Spinocerebellar ataxia (SCA).
In recent years there has been tremendous growth in research on cerebral functions. The cerebellum is recognized as a unique and a key structure in the central nervous system, controlling more neurons than all other regions of the brain.
The cerebellum is the primary center for motor control, and co - ordination but also increasingly implicated in higher cognitive functions. Support and advocacy groups can help you to connect with patients and families, and they can provide valuable services. Many develop patient - centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources and services.
So, we can say that the patients with Spinocerebellar ataxia (SCA] have important balance impairment and risk of falls that influence the ability to function such as self cares, transfers and locomotion. Furthermore, the more severe ataxia is, the more comprised are postural balance, risk of falls and ability to function.